FILTER

FILTERED INTERVIEW RESULTS

Joe Walsh

MANAGING DIRECTOR, LEPIDICO
Lepidico is fast developing its integrated lithium operation, from its’ mine in Namibia to producing derived chemicals from plants to be built in UAE.

Bruce Anderson

BRUCE ANDERSON, CEO, 247SOLAR
247Solar explains to GBR why its unique Heat2Power turbines can provide clean, reliable and cheap energy to off-grid mines.

Marcelo Schumacker

COUNTRY DIVISION MANAGER, ABB CHILE
ABB explains why Chile provides an excellent market for its mining technologies.

Sandro Tavonatti

CEO, SIGDO KOPPERS INGENIERÍA Y CONSTRUCCIÓN (SKIC)
Sigdo Koppers Ingeniería y Construcción (SKIC) explains how it operates with Chile’s largest mines.

Florencio Castro & Alexandra Almenara

VP – PERU & VP ENVIRONMENT AND SUSTAINABILITY – SOUTH AMERICA, AUSENCO
Ausenco in Peru relates how it is developing the capacity to provide an integral service of engineering, environmental and social services to any project at any stage of their life cycle.

Belisario Tijero

GENERAL MANAGER – PERU, MASTER DRILLING
Master Drilling updates GBR on current drilling trends in Peru.

Hugo Salamanca

PRESIDENT, HIGHSERVICE CORP
HighService Corp in Chile explains its’ vision is to become a leading robotics company worldwide in the mining and heavy industry sectors.

Fernando de la Lastra & Joerg von Loebenstein

GENERAL MANAGER AND CO-FOUNDER & ENGINEERING MANAGER AND CO-FOUNDER, TECNIPAK
Technopak in Chile explains how its specialisation in mineral conveyer systems offers global potential.

Martin Preece

EXECUTIVE VICE PRESIDENT SOUTH AFRICA, GOLD FIELDS
Gold Fields relates how its’ South Deep mine in South Africa is perfoming.

Benjamin Quijandria

CEO, MINING CLUSTER OF SOUTHERN PERU (CMSP)
Mining Cluster if Southern Peru (CMSP) explains how it was inspired into being by the success of the mining clusters in Chile and Australia.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS